Turning cancer's metabolic plasticity into fragility- an evolving paradigm

Research output: Contribution to journalArticle

Abstract

In an elegant report, Corbet et al1 recently demonstrated the much needed insight to exploit cancer's metabolic reprogramming for potential therapeutic intervention. In brief, the findings underscore the principle that abrogation of mitochondrial pyruvate metabolism upregulates glycolysis, and sensitizes cancer cells to radiation. Distinctive from the conventional approach of inhibition/ down-regulation of glycolysis, this emerging paradigm of forced-upregulation of glycolysis (i.e., a “hyperglycolytic” phenotype) concomitant with a reduced mitochondrial capacity turns the metabolic plasticity into vulnerability that may have implications in therapeutic targeting. Nevertheless, this commendable report1 also provokes scientific curiosity and future directions of research on the opportunities and challenges of such forced upregulation of glycolysis in cancer.

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalCancer Biology and Therapy
DOIs
StateAccepted/In press - May 24 2018

Fingerprint

Glycolysis
Up-Regulation
Neoplasms
Exploratory Behavior
Pyruvic Acid
Down-Regulation
Radiation
Phenotype
Therapeutics
Research

Keywords

  • aerobic glycolysis
  • metabolic plasticity
  • mitochondrial OxPhos
  • mitochondrial pyruvate carrier

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

@article{fd664d856ad742cba8cf186af4543c87,
title = "Turning cancer's metabolic plasticity into fragility- an evolving paradigm",
abstract = "In an elegant report, Corbet et al1 recently demonstrated the much needed insight to exploit cancer's metabolic reprogramming for potential therapeutic intervention. In brief, the findings underscore the principle that abrogation of mitochondrial pyruvate metabolism upregulates glycolysis, and sensitizes cancer cells to radiation. Distinctive from the conventional approach of inhibition/ down-regulation of glycolysis, this emerging paradigm of forced-upregulation of glycolysis (i.e., a “hyperglycolytic” phenotype) concomitant with a reduced mitochondrial capacity turns the metabolic plasticity into vulnerability that may have implications in therapeutic targeting. Nevertheless, this commendable report1 also provokes scientific curiosity and future directions of research on the opportunities and challenges of such forced upregulation of glycolysis in cancer.",
keywords = "aerobic glycolysis, metabolic plasticity, mitochondrial OxPhos, mitochondrial pyruvate carrier",
author = "Shanmugasundara Ganapathy",
year = "2018",
month = "5",
day = "24",
doi = "10.1080/15384047.2018.1471441",
language = "English (US)",
pages = "1--3",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",

}

TY - JOUR

T1 - Turning cancer's metabolic plasticity into fragility- an evolving paradigm

AU - Ganapathy, Shanmugasundara

PY - 2018/5/24

Y1 - 2018/5/24

N2 - In an elegant report, Corbet et al1 recently demonstrated the much needed insight to exploit cancer's metabolic reprogramming for potential therapeutic intervention. In brief, the findings underscore the principle that abrogation of mitochondrial pyruvate metabolism upregulates glycolysis, and sensitizes cancer cells to radiation. Distinctive from the conventional approach of inhibition/ down-regulation of glycolysis, this emerging paradigm of forced-upregulation of glycolysis (i.e., a “hyperglycolytic” phenotype) concomitant with a reduced mitochondrial capacity turns the metabolic plasticity into vulnerability that may have implications in therapeutic targeting. Nevertheless, this commendable report1 also provokes scientific curiosity and future directions of research on the opportunities and challenges of such forced upregulation of glycolysis in cancer.

AB - In an elegant report, Corbet et al1 recently demonstrated the much needed insight to exploit cancer's metabolic reprogramming for potential therapeutic intervention. In brief, the findings underscore the principle that abrogation of mitochondrial pyruvate metabolism upregulates glycolysis, and sensitizes cancer cells to radiation. Distinctive from the conventional approach of inhibition/ down-regulation of glycolysis, this emerging paradigm of forced-upregulation of glycolysis (i.e., a “hyperglycolytic” phenotype) concomitant with a reduced mitochondrial capacity turns the metabolic plasticity into vulnerability that may have implications in therapeutic targeting. Nevertheless, this commendable report1 also provokes scientific curiosity and future directions of research on the opportunities and challenges of such forced upregulation of glycolysis in cancer.

KW - aerobic glycolysis

KW - metabolic plasticity

KW - mitochondrial OxPhos

KW - mitochondrial pyruvate carrier

UR - http://www.scopus.com/inward/record.url?scp=85047431522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047431522&partnerID=8YFLogxK

U2 - 10.1080/15384047.2018.1471441

DO - 10.1080/15384047.2018.1471441

M3 - Article

C2 - 29723104

AN - SCOPUS:85047431522

SP - 1

EP - 3

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

ER -